LINC01284

Across TCGA pan-cancer cohorts, LINC01284 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated LINC01284 data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher LINC01284 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC01284 expression acts as an unfavorable survival marker, although some lineages such as PAAD and CESC show a favorable association.

COAD, PAAD, and CESC are the cancer types where LINC01284 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Tertile	III,IV	0.282	0.579	.002	72	view →
PAAD	DFS	Median	All	0.661	0.384	<.001	50	view →
CESC	OS	Tertile	II,III,IV	1.000	0.796	.019	48	view →
LUSC	OS	Tertile	III,IV	0.310	0.716	<.001	39	view →
KIRP	DFS	Tertile	III,IV	1.000	0.305	.017	38	view →
KICH	DFS	Tertile	III,IV	0.025	0.773	<.001	18	view →
READ	DFS	Tertile	III,IV	0.174	0.747	.005	18	view →
UCEC	DFS	Tertile	All	0.480	0.697	.016	18	view →
LIHC	OS	Tertile	III,IV	0.059	0.738	<.001	18	view →
ESCA	DFS	Quartile	III,IV	0.546	0.258	.007	14	view →
BLCA	DFS	Tertile	IV	0.226	0.497	.046	9	view →
ACC	OS	Tertile	All	0.955	0.818	.022	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

LINC01284–COAD (DFS)

Open the COAD breakdown →